Book
The end of Alzheimer's : the first program to prevent and reverse cognitive decline / Dale E. Bredesen, MD.
Record details
- ISBN: 9780735216204 (hardcover)
- Physical Description: 308 pages : illustrations ; 24 cm
- Publisher: New York : Avery, an imprint of Penguin Random House, [2017]
- Copyright: ©2017
Content descriptions
| Bibliography, etc. Note: | Includes bibliographical references and index. |
| Formatted Contents Note: | Disrupting dementia -- Patient zero -- How does it feel to come back from dementia? -- How to give yourself Alzheimer's : a primer -- Wit's end : from bedside to bench and back -- The God gene and the three types of Alzheimer's disease -- The "cognoscopy" : where do you stand? -- ReCODE : reversing cognitive decline -- Success and the social network : two people's daily routines -- Putting it all together : you can do it -- This is not easy : workarounds and crutches -- Resistance to change : Machiavelli meets Feynman. |
Search for related items by subject
| Subject: | Alzheimer's disease > Treatment. Alzheimer's disease > Prevention. |
Available copies
- 1 of 1 copy available at Tsuga Consortium.
Holds
- 0 current holds with 1 total copy.
Show Only Available Copies
| Location | Call Number / Copy Notes | Barcode | Shelving Location | Status | Due Date |
|---|---|---|---|---|---|
| Lakeshore Branch | 616.8311 Bre | 31681010066017 | NONFIC | Available | - |
Dale Bredesen, M.D., is internationally recognized as an expert in the mechanisms of neurodegenerative diseases such as Alzheimerâs disease. He graduated from Caltech, then earned his M.D. from Duke University Medical Center in Durham, North Carolina. He served as chief resident in neurology at the University of California, San Francisco (UCSF) before joining Nobel laureate Stanley Prusinerâs laboratory at UCSF as an NIH postdoctoral fellow. He held faculty positions at UCSF, UCLA, and the University of California, San Diego. Dr. Bredesen directed the Program on Aging at the Burnham Institute before coming to the Buck Institute in 1998 as its founding president and CEO. He is the chief medical officer of MPI Cognition.
